A phase I multiple-ascending dose clinical trial of APD371
Phase of Trial: Phase I
Latest Information Update: 09 May 2016
At a glance
- Drugs APD 371 (Primary)
- Indications Pain
- Focus Adverse reactions
- 09 May 2016 According to an Arena Pharmaceuticals media release, favourable results from this trial were announced in the first quarter of 2016.
- 09 May 2016 Status changed from recruiting to completed, as per information provided in an Arena Pharmaceuticals media release.
- 29 Oct 2015 Status changed from planning to recruiting, according to an Arena Pharmaceuticals media release.